Polyplus-transfection
Illkirch-graffenstaden · Founded 2001
About Polyplus-transfection
Polyplus-transfection SA is a biotechnology company that develops, markets and sells innovative solutions for the in vivo, in vitro and ex vivo delivery of nucleic acids in research, bioproduction and therapeutics. Located close to the University of Strasbourg in Eastern France, Polyplus-transfection has been ISO 9001-certified since 2002 and supplies its proprietary range of reagents for the transfection of genes, oligonucleotides and siRNA through a worldwide distributor network. Polyplus reagents are involved in a growing number of clinical trials worldwide. In addition, Polyplus-transfection holds a broad estate of patents and licenses including original methods for therapeutic siRNA delivery.
Company Facts
- Founded: 2001
- Legal name: Polyplus-transfection SA
- Operating status: Acquired
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.2M
- Funding stage: M&A
- Last round: Series Unknown (Jan 2011)
- Website: polyplus-transfection.com
- Phone: +33 3 90 40 61 80
Social Profiles
Canonical: https://fsome.com/organization/polyplus-transfection-8241300 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.